Ilaris 150 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FDL51
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,310
Award facts
- Contract value 100% obligated
- $51,310.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $51,310.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Ilaris 150 mg/ml vials, with an ultimate completion date of September 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the vendor's Park Ridge, IL location and represents a specific product fulfillment under the company's broader federal pharmaceutical supply agreements.
This delivery order is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The parent contract, part of the DLA's SPE2DB program, enables the agency to procure an extensive portfolio of pharmaceutical products, biologics, and medical supplies for Department of Defense healthcare facilities worldwide. Ilaris (canakinumab), an anti-inflammatory biologic medication, supports the military health system's specialized pharmaceutical needs. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, vaccines, oncology treatments, and other specialized medical products to defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FDL51?
SPE2DB25FDL51 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FDL51 worth?
The government has obligated $51,310 on SPE2DB25FDL51.
Is contract SPE2DB25FDL51 an order under another contract?
Yes. SPE2DB25FDL51 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL51 competed?
The extent of competition for SPE2DB25FDL51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award